Nifty Pharma Today: Index Falls 1.30% as Selling Broadens

Updated: 14 Oct 2026 • 4:20 pm

Posted by:

Nifty Pharma Today: Index Falls 1.30% as Selling Broadens

In an end-of-session wrap for 14 October 2026, Nifty Pharma closed lower as selling extended across most of the sector. The index fell 1.30% to 25,736.95, with 19 of its 20 stocks ending in the red. This update reflects prices as of 4:15:00 PM IST.

Quick sector takeaways

Nifty Pharma fell 338.05 points, or 1.30%, to close at 25,736.95 versus the previous close of 26,075.00.
Breadth was decisively negative: 19 stocks declined and one stock advanced.
JB Chemicals & Pharmaceuticals, Divi's Laboratories and Dr. Reddy's Laboratories were among the sharpest fallers, while Abbott India rose 2.34%.
For the next session, watch whether the index holds above its day's low of 25,600.95 and whether the breadth improves from the 1:19 advance-decline split.

Nifty Pharma today: broad pressure at the close

Nifty Pharma today ended as the weakest sector index in the session, closing 338.05 points below its previous close. The index opened at 26,058.55 and reached an intraday high of 26,062.65, before moving lower to touch 25,600.95. Its close at 25,736.95 was above the low but remained firmly below the opening and previous close.

The closing picture was defined by broad-based weakness rather than a narrowly isolated move. Several major pharmaceutical names ended lower, while Abbott India was the sole stock in the green. The gap between the day's high and low was 461.70 points, showing a session in which the index moved meaningfully away from its early levels.

Price snapshot

Nifty Pharma closed at 25,736.95, down from 26,075.00 in the prior session. The 338.05-point fall translates into a 1.30% decline. The index traded between a high of 26,062.65 and a low of 25,600.95 after opening at 26,058.55. The close was 135.00 points above the intraday low and 325.70 points below the intraday high.

These levels frame the immediate price action without assigning a cause. Readers tracking the sector can follow the Nifty Pharma screener alongside the broader Univest Market View.

Sector ranking

Nifty Pharma was the top losing sector index among the tracked Indian NSE sector indices on 14 October. The complete session ranking, from the strongest gain to the steepest fall, was: Nifty FMCG, up 1.21%; Nifty IT, up 1.14%; Nifty Mid Select, up 0.08%; Nifty Bank, down 0.30%; Nifty Metal, down 0.67%; Nifty Auto, down 0.93%; Nifty Financial Services, down 1.11%; and Nifty Pharma, down 1.30%.

The comparison places pharma behind every other index in this group for the day. FMCG and IT led the gainers, Nifty Mid Select ended marginally higher, and the remaining sector indices closed lower, with pharma recording the largest percentage decline.

Constituent breadth

The sector's breadth underscored the negative close. Of the 20 Nifty Pharma stocks, one advanced, 19 declined and none were unchanged. That produces an advance-decline ratio of 0.05, or one advancing stock for every 19 declining stocks. Such a distribution shows that the sector's fall was spread across its stocks rather than limited to only a few counters.

Abbott India was the lone gainer, whereas stocks ranging from larger pharmaceutical companies to other sector names finished lower. The breadth reading will remain a useful measure to monitor next session alongside the index level.

Heavyweights versus broader participation

Weakness was visible among key sector names. Sun Pharmaceutical Industries declined 1.37%, Divi's Laboratories fell 2.82%, Torrent Pharmaceuticals lost 1.35%, Cipla moved down 1.13%, and Dr. Reddy's Laboratories dropped 1.94%. These widely watched names were also among the stocks in focus through the session.

The direction across these companies aligned with the wider 19:1 negative breadth. Divi's Laboratories was notably softer at ₹9,023.00, while Sun Pharmaceutical Industries ended at ₹1,746.40 and Torrent Pharmaceuticals at ₹4,580.00.

Key Nifty Pharma stocks

Stock	Move	Why it matters
JB Chemicals & Pharmaceuticals	-3.87% to ₹2,408.90	It was the steepest percentage decliner in the sector.
Divi's Laboratories	-2.82% to ₹9,023.00	Its decline stood out among the sector's key names.
Abbott India	+2.34% to ₹26,295.00	It was the only advancing Nifty Pharma stock.
Dr. Reddy's Laboratories	-1.94% to ₹1,216.00	It added to the broad weakness in major pharma names.
Sun Pharmaceutical Industries	-1.37% to ₹1,746.40	Its lower close matched the sector-wide negative trend.

Biggest positive movers

Abbott India was the sector's biggest and only positive mover, gaining ₹600.00, or 2.34%, to ₹26,295.00. It traded between ₹25,750.00 and ₹26,550.00 during the session. Its gain offered a counterpoint to the otherwise weak sector breadth.

Biggest negative movers

JB Chemicals & Pharmaceuticals led the losses, falling ₹97.10 or 3.87% to ₹2,408.90. Divi's Laboratories followed with a 2.82% fall, while Dr. Reddy's Laboratories, Mankind Pharma and Sun Pharmaceutical Industries declined 1.94%, 1.56% and 1.37%, respectively. These moves were consistent with the lower close for the sector index.

Stocks to watch next session

Abbott India, after closing higher while the rest of the sector was mostly lower.
JB Chemicals & Pharmaceuticals, following its 3.87% fall.
Divi's Laboratories, after ending at ₹9,023.00, above its intraday low of ₹8,937.50.
Dr. Reddy's Laboratories, which closed at ₹1,216.00 after touching ₹1,209.60.
Sun Pharmaceutical Industries, which ended at ₹1,746.40 after a low of ₹1,725.50.

The constructive case

The positive evidence within the session came from Abbott India's 2.34% gain and from the index closing above its intraday low. The index recovered 135.00 points from 25,600.95 by the close, even though it remained lower for the day. Abbott India's move shows that performance was not uniformly negative at the individual-stock level.

A more constructive next-session picture would involve improvement in the number of advancing stocks alongside a move away from the day's low. Those are observable measures that investors can track without drawing conclusions beyond the session's price action.

The cautious case

The cautious case is centred on the scale of the decline and the breadth behind it. Nifty Pharma was the weakest index in the session ranking, and 19 of 20 sector stocks declined. The index also closed below its opening level and below the previous close.

Losses in several prominent names, including Divi's Laboratories, Sun Pharmaceutical Industries, Torrent Pharmaceuticals, Cipla and Dr. Reddy's Laboratories, accompanied the broad negative breadth. Whether this breadth remains similarly weak or begins to improve will be important in assessing the next session's participation.

Univest Insights

Nifty Pharma today presented a clear split between one strong gainer and widespread declines elsewhere. Abbott India's advance was meaningful in isolation, but it did not change the overall breadth outcome or the index's position as the session's top losing sector index.

The index's path from an opening of 26,058.55 to a close of 25,736.95 highlights sustained pressure during the day. Its finish above 25,600.95 shows some distance from the low, while the close remained well below the 26,062.65 high.

For sector participants, the next session can be read through two simple lenses: the index's position within its recent intraday range and the direction of participation across pharma stocks. The breadth reading is especially relevant because it captures whether movement is becoming more widespread or more selective.

In the next session, watch Nifty Pharma's 25,600.95 intraday low and whether the 1:19 advance-decline reading improves.

Published on 14 October 2026 at 4:18 PM IST

Frequently asked questions

How did Nifty Pharma perform today?

Nifty Pharma fell 338.05 points, or 1.30%, to close at 25,736.95 on 14 October 2026.

What was Nifty Pharma's previous close?

The previous close was 26,075.00.

What were Nifty Pharma's intraday high and low?

The index recorded an intraday high of 26,062.65 and a low of 25,600.95.

Why was Nifty Pharma the top losing sector index?

It posted the largest percentage decline among the listed sector indices, falling 1.30% in the session.

Which Nifty Pharma stock gained today?

Abbott India gained 2.34% to close at ₹26,295.00.

Which stocks were the biggest Nifty Pharma losers?

JB Chemicals & Pharmaceuticals fell 3.87%, Divi's Laboratories declined 2.82%, and Dr. Reddy's Laboratories lost 1.94%.

Disclaimer

Investments in securities markets are subject to market risks. Read all related documents carefully before investing. This sector-index update is for informational and educational purposes only and is not personalized investment advice or a recommendation to buy, sell, or hold any security.